Grey Wolf`s ERAP1 Inhibitor GRWD5769 First Clinical Data At ASCO
03 Jun 2024 //
PR NEWSWIRE
Grey Wolf To Show First ERAP1 Inhibitor GRWD5769 Data At ASCO
30 May 2024 //
PR NEWSWIRE
Grey Wolf $50M Series B: For Antigen Modulation Tech Expansion
23 May 2024 //
PR NEWSWIRE
Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collab
18 Apr 2023 //
PR NEWSWIRE
Grey Wolf Announces Dosing of First Patient in Phase 1/2 Study of GRWD5769
28 Mar 2023 //
PR NEWSWIRE
Grey Wolf Closes Oversubscribed $49 Million Series B Financing
26 Jan 2023 //
PR NEWSWIRE